UK MHRA Inspector Highlights Mistakes Made In Decentralized Clinical Trials

 
• By Vibha Sharma

Inadequate risk assessments, participant confidentiality breaches and issues with documenting and verifying clinical trial activities have emerged as recurring themes in inspections of decentralized clinical trials by the UK medicines regulator.

3d rendering humanoid robot with headset on white background
For Remote Consent, MHRA Expects Checks To Authenticate A Trial Participant’s Identity • Source: Shutterstock

More from Clinical Trials

More from R&D